Please assess the completion status of the following clinical trial:

Trial Title: Breathalyzer Validation Study

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 21-39 old~* Less than 4 drinking days and less than 12 drinks per week on average in the past 2 months~* Have previously consumed four (women) or five (men) or more standard drinks without problems~* A valid photo ID~* Willing to take public transportation home, via septa or an uber rideshare credit.~Exclusion Criteria:~* Desire alcohol treatment now or received it in the past 6 months~* Alcohol dependence with withdrawal per DSM-V criteria~* Non-English-speaking~* Individuals who have a medical condition or who are taking medication which limits or prevents the consumption of alcohol.

- Gender: ALL
- Minimum Age: 21 Years
- Maximum Age: 39 Years
- Healthy Volunteers: t

Study Arms:
- Commercial Smartphone-paired breathalyzers-Set 1 (Type: EXPERIMENTAL): All subjects will first be given a priming dose of alcohol containing vodka designed to raise the blood alcohol content based on weight and gender. Blood alcohol content will first be measured with three commercial smartphone-paired breathalyzers: Drivesafe Evoc, Alcohoot, and BacTrack Pro which will be tested in a randomized order and recorded. Participants blood alcohol content will also be measured using the Intoxilyzer 240, a police grade breathalyzer device After the tertiary dose of alcohol, a nurse will perform a blood draw on the participants, which will be used to determine blood alcohol content.
- Commercial Smartphone-paired breathalyzers-Set 2 (Type: EXPERIMENTAL): All subjects will first be given a priming dose of alcohol containing vodka designed to raise the blood alcohol content based on weight and gender. Blood alcohol content will first be measured with three commercial smartphone-paired breathalyzers: BACtrack Vio, Drinkmate, and Floome which will be tested in a randomized order and recorded. Participants blood alcohol content will also be measured using the Intoxilyzer 240, a police grade breathalyzer device After the tertiary dose of alcohol, a nurse will perform a blood draw on the participants, which will be used to determine blood alcohol content.

Based on this trial design, predict the completion outcome and termination type (if applicable).